Salix Pharmaceuticals, Ltd. Credit Rating

Registered User

Please log in for full access to your permissions. Password is case sensitive.

User Name:

Password:

Automatically log me in when I return

Forgot your Username or Password?

Or Log In using:

Not Registered Yet?

Register now to get FREE access to:

Issuer Ratings.

Ratings on over 170,000 corporate, government and structured finance securities.

Events Calendar.

Information about training seminars, briefings, and teleconferences.

Watchlists.

Listings of issuers under review for rating changes.

Rating Methodologies.

Descriptive frameworks underlying Moody's ratings.

Results 1 - 17 Of 17

Page 1 Of 1 Next

Filter By:

Date	Document Type	Title	Source
26 Feb 2015	Issuer Comment	Valeant's Debt-Funded Acquisition of Salix Is Credit Negative	Moody's Investors Service
23 Feb 2015	Rating Action	Moody's reviews Salix's ratings for upgrade	Moody's Investors Service
30 Jan 2015	Announcement	Moody's: Salix restatement is credit negative	Moody's Investors Service
30 Jan 2015	Issuer Comment	Salix Pharmaceuticals, Ltd.: Salix restatement is credit negative	Moody's Investors Service
22 Dec 2014	Credit Opinion	Salix Pharmaceuticals, Ltd.	Moody's Investors Service
22 Dec 2014	LGD Assessment	Salix LGD Report	Moody's Investors Service
19 Dec 2014	Rating Action	Moody's confirms Salix Pharmaceuticals at B1; negative outlook	Moody's Investors Service
07 Nov 2014	Rating Action	Moody's reviews Salix Pharmaceuticals' ratings for downgrade	Moody's Investors Service
03 Oct 2014	Announcement	Moody's: Salix's termination of Cosmo merger removes a credit positive	Moody's Investors Service
03 Oct 2014	Issuer Comment	Salix Pharmaceuticals, Ltd.: Salix's termination of Cosmo deal eliminates a credit positive	Moody's Investors Service
14 Jul 2014	Issuer Comment	Salix Pharma to Merge with Cosmo and Relocate to Ireland, a Credit Positive	Moody's Investors Service
09 Jul 2014	Announcement	Moody's: Cosmo Merger is Credit Positive for Salix	Moody's Investors Service
09 Jul 2014	Issuer Comment	Cosmo Merger is Credit Positive for Salix	Moody's Investors Service
02 Jan 2014	LGD Assessment	Salix Pharmaceuticals, Ltd.	Moody's Investors Service
11 Dec 2013	Announcement	Moody's Publishes Covenant Quality Assessment for Salix Pharmaceuticals, Ltd. Bond Offering	Moody's Investors Service
11 Dec 2013	Covenant Quality Assessment	Salix Pharmaceuticals, Ltd. - Pre-Sale Snapshot - $750m _% Senior Notes due 2021	Moody's Investors Service
02 Dec 2013	Rating Action	Moody's assigns B1 CFR to Salix Pharmaceuticals; stable outlook	Moody's Investors Service

Results 1 - 17 Of 17

Page 1 Of 1 Next